L1 retrotransposition is regulated post-transcriptionally In High-Grade Serous Ovarian Cancer
Pradhan, B.; Zhang, K.; Li, Y.; Lavikka, K.; Muranen, T.; Huhtinen, K.; Badge, R. M.; Burns, K.; Hynninen, J.; Hietanen, S.; Oikkonen, J.; Hautaniemi, S.; Kauppi, L.
Show abstract
L1 retrotransposons are the only protein-coding active transposable elements in the human genome. Although silenced during normal conditions, they are highly expressed in human epithelial cancers including high-grade serous ovarian cancer (HGSC), where they transcribe to form L1 mRNA and subsequently integrate into the genome by a process called retrotransposition. Despite of high L1 protein expression in the earliest phases of HGSC, these tumors do not accrue many somatic L1 insertions. To understand this unexplained disconnect, we monitored the transcription and retrotransposition activity of two frequently expressed retrotransposition-competent (RC)-L1 (RC-L1) in 64 clinical tumor specimens from 34 HGSC patients and found that despite the presence of RC-L1 mRNA, a third of samples did not acquire somatic L1 insertions. In addition to high inter-patient variability in retrotransposition frequency, there was remarkable intra-patient heterogeneity in L1 insertion patterns between tumor sites, indicating that L1 retrotransposition is highly dynamic in vivo. Comparison of genomic and transcriptomic features of L1-null tumors with L1-high tumors (those with [≥]5 somatic L1 insertions) showed that retrotransposition was favored by increased rate of cell proliferation.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Co-regulation and functional cooperativity of FOXM1 and RHNO1 bidirectional genes in ovarian cancer 94%
- An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma 94%
- Systematic lncRNA mapping to genome-wide co-essential pathways uncovers cancer dependency on uncharacterized lncRNAs 94%
Similar papers in this journal
- Cancer LncRNA Census 2 (CLC2): an enhanced resource reveals clinical features of cancer lncRNAs 94%
- The DNA Damage Response (DDR) landscape of endometrial cancer defines discrete disease subtypes and reveals therapeutic opportunities. 94%
- Analysis of gene expression and mutation data points on contribution of transcription to the mutagenesis by APOBEC enzymes 94%
Similar papers in this journal
Similar papers in this journal
- RetroTest unravels LINE-1 retrotransposition in Head and Neck Squamous Cell Carcinoma 95%
- Cis-regulatory effect of HPV integration is constrained by host chromatin architecture in cervical cancers 93%
- USP28 enables oncogenic transformation of respiratory cells and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K. 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.